93 related articles for article (PubMed ID: 20649515)
41. Lethal reperfusion injury in acute myocardial infarction: facts and unresolved issues.
Garcia-Dorado D; Ruiz-Meana M; Piper HM
Cardiovasc Res; 2009 Jul; 83(2):165-8. PubMed ID: 19502282
[No Abstract] [Full Text] [Related]
42. Effects of ischemic preconditioning on myocardial protective on cardiac surgery: possibility of ischemic preconditioning and adenosine administration.
Funahashi M
Ann Thorac Cardiovasc Surg; 2003 Oct; 9(5):307-13. PubMed ID: 14672527
[TBL] [Abstract][Full Text] [Related]
43. Myocardial damage prevented by volatile anesthetics: a multicenter randomized controlled study.
Guarracino F; Landoni G; Tritapepe L; Pompei F; Leoni A; Aletti G; Scandroglio AM; Maselli D; De Luca M; Marchetti C; Crescenzi G; Zangrillo A
J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):477-83. PubMed ID: 16884976
[TBL] [Abstract][Full Text] [Related]
44. Effects of trimetazidine on myocardial preconditioning in anesthetized rats.
Kara AF; Demiryürek S; Celik A; Tarakçioğlu M; Demiryürek AT
Eur J Pharmacol; 2004 Oct; 503(1-3):135-45. PubMed ID: 15496308
[TBL] [Abstract][Full Text] [Related]
45. Adenosine-A1 receptors activation restores the suppressed cardioprotective effects of ischemic preconditioning in hyperhomocysteinemic rat hearts.
Balakumar P; Singh H; Reddy K; Anand-Srivastava MB
J Cardiovasc Pharmacol; 2009 Sep; 54(3):204-12. PubMed ID: 19568176
[TBL] [Abstract][Full Text] [Related]
46. Cardioprotective effects of electroacupuncture pretreatment on patients undergoing heart valve replacement surgery: a randomized controlled trial.
Yang L; Yang J; Wang Q; Chen M; Lu Z; Chen S; Xiong L
Ann Thorac Surg; 2010 Mar; 89(3):781-6. PubMed ID: 20172127
[TBL] [Abstract][Full Text] [Related]
47. Mechanisms of cardiac preconditioning: ten years after the discovery of ischemic preconditioning.
Meldrum DR
J Surg Res; 1997 Nov; 73(1):1-13. PubMed ID: 9441786
[TBL] [Abstract][Full Text] [Related]
48. Protective effect of labedipinedilol-A, a novel dihydropyridine-type calcium channel blocker, on myocardial apoptosis in ischemia-reperfusion injury.
Liang JC; Chen HR; Chiu CC; Liou SF; Chen IJ; Yeh JL
Life Sci; 2006 Aug; 79(13):1248-56. PubMed ID: 16647091
[TBL] [Abstract][Full Text] [Related]
49. Worsening of long-term myocardial function after successful pharmacological pretreatment with cyclosporine.
Laudi S; Weimann J; Haschke M; Trump S; Schmitz V; Christians U; Kaisers U; Steudel W
J Physiol Pharmacol; 2007 Mar; 58(1):19-32. PubMed ID: 17440223
[TBL] [Abstract][Full Text] [Related]
50. Editorial overview: cardioprotective drugs for myocardial ischemic injury--a therapeutic area at risk.
Knight DR
Curr Opin Investig Drugs; 2007 Mar; 8(3):190-2. PubMed ID: 17408113
[No Abstract] [Full Text] [Related]
51. Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury.
Argaud L; Gateau-Roesch O; Muntean D; Chalabreysse L; Loufouat J; Robert D; Ovize M
J Mol Cell Cardiol; 2005 Feb; 38(2):367-74. PubMed ID: 15698843
[TBL] [Abstract][Full Text] [Related]
52. CardioPulse: Cyclosporine to reduce myocardial infarction injury?
Nicholls M
Eur Heart J; 2016 Jan; 37(3):210-1. PubMed ID: 27471760
[No Abstract] [Full Text] [Related]
53. Closing the pore on reperfusion injury: myocardial protection with cyclosporine.
Muehlschlegel JD
Anesthesiology; 2014 Aug; 121(2):212-3. PubMed ID: 24895914
[No Abstract] [Full Text] [Related]
54. [Cyclosporine A: from immunomodulation to prevention of ischemia-reperfusion injuries].
Gennai S; Pison C; Briot R
Ann Fr Anesth Reanim; 2013 Dec; 32(12):886-7. PubMed ID: 24199903
[No Abstract] [Full Text] [Related]
55. CIRCUS: a kiss of death for cardioprotection?
Heusch G
Cardiovasc Res; 2015 Nov; 108(2):215-6. PubMed ID: 26410370
[No Abstract] [Full Text] [Related]
56. The effect of metformin on cardiac fibrosis via differentiation of cardiac fibroblasts.
Ünlü M; Balta Ş; Arslan Z; Öztürk C; Çelik T; Iyisoy A
Cardiology; 2015; 130(1):52-3. PubMed ID: 25531655
[No Abstract] [Full Text] [Related]
57. Noble gases as cardioprotectants - translatability and mechanism.
Smit KF; Weber NC; Hollmann MW; Preckel B
Br J Pharmacol; 2015 Apr; 172(8):2062-73. PubMed ID: 25363501
[TBL] [Abstract][Full Text] [Related]
58. Response to the paper by Ünlü et al. entitled 'The effect of metformin on cardiac fibrosis via differentiation of cardiac fibroblasts'.
Li J; Song SJ
Cardiology; 2015; 130(1):54. PubMed ID: 25531774
[No Abstract] [Full Text] [Related]
59. Cardioprotection and arrhythmias, Part I.
Baczkó I; Jost N; Varró A
Can J Physiol Pharmacol; 2015 Jul; 93(7):v. PubMed ID: 26444056
[No Abstract] [Full Text] [Related]
60. Treating percutaneous coronary intervention-related myocardial injury with metformin.
Calvert JW
Cardiology; 2014; 127(2):130-2. PubMed ID: 24335004
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
